Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-25 @ 4:54 AM
NCT ID:
NCT00829218
Eligibility Criteria:
Inclusion Criteria:
* Men and women aged 18-75 who fulfill criteria for Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM)
* They must live in the greater Portland, OR, metro area, have transportation to/from study site, have access to email
* Willing to discontinue medications with bowel altering side effects
Exclusion Criteria:
* Asthma
* Inflammatory bowel disease
* Colon cancer or active endometriosis
* Any major abdominal surgery (excluding caesarean section, tubal ligation, hernia repair, gall bladder removal or appendectomy)
* Female and pregnant
* Currently taking pregabalin, gabapentin, or anti-psychotic medications and are unwilling/ unable to discontinue use
* Suffered from alcohol/substance abuse or psychosis in the last two years.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00829218
Study Brief:
Protocol Section:
NCT00829218